Area method for the estimation of partition coefficients for physiological pharmacokinetic models

  • James M. Gallo
  • Fred C. Lam
  • Donald G. Perrier
Pharmacometrics

Abstract

A new technique, the area method, is derived for the determination of partition coefficients for both blood-flow limited and membrane limited physiological pharmacokinetic models. This method was compared to a standard technique by Monte Carlo simulation. Partition coefficients were calculated for the blood-flow limited case for both eliminating and noneliminating organs. It was found that the area method compared favorably to a standard technique and was less prone to error. This may be attributed to the more subjective interpretation as to which data points are included in the terminal phase, since the standard method relies on the accurate determination of the terminal slope for the calculation of partition coefficients. Both methods are satisfactory for the calculation of partition coefficients with the area method being more accurate and precise.

Key words

physiological pharmacokinetic models partition coefficients parameter estimation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    L. E. Gerlowski and R. K. Jain. Physiologically based pharmacokinetic modelling: Principles and applications.J. Pharm. Sci. 72:1103–1127 (1983).PubMedCrossRefGoogle Scholar
  2. 2.
    R. J. Lutz, R. L. Dedrick, and D. S. Zaharko. Physiological pharmacokinetics: an in vivo approach to membrane transport.Pharmacol. Ther. 11:559–592 (1980).PubMedCrossRefGoogle Scholar
  3. 3.
    H. S. G. Chen and J. F. Gross. Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic models.J. Pharmacokin. Biopharm. 7:117–125 (1979).CrossRefGoogle Scholar
  4. 4.
    J. H. Lin, Y. Sugiyama, S. Awazu, and M. Hanano. In vitro and in vivo evaluation of the partition coefficients for physiological pharmacokinetic models.J. Pharmacokin. Biopharm. 10:637–647 (1982).CrossRefGoogle Scholar
  5. 5.
    F. G. King and R. L. Dedrick. Physiologic model for the pharmacokinetics of 2' deoxycoformycin in normal and leukemic mice.J. Pharmacokin. Biopharm. 9:519–534 (1981).CrossRefGoogle Scholar
  6. 6.
    J. M. Weissbrod, D.Sc. thesis, A comprehensive approach to whole body pharmacokinetics in mammalian systems: applications to methotrexate, streptozotocin, and zinc. Columbia University (1979).Google Scholar
  7. 7.
    O. Nelson, M.S. thesis, Physiologic pharmocokinetic modeling. University of Arizona, Tuscon (1977).Google Scholar
  8. 8.
    International Mathematical and Statistical Library, Houston, TX (1982).Google Scholar
  9. 9.
    F. Ichimura, K. Yokogawa, T. Yamana, A. Tsiju, and Y. Mizukami. Physiological pharmacokinetic model for pentazocine. I. Tissue distribution and elimination in the rat.Int. J. Pharm. 15:321–322 (1983).CrossRefGoogle Scholar
  10. 10.
    J. L. Gabrielsson, L. K. Paalzow, and L. Nordström. A physiologically based pharmacokinetic model for theophylline dispositon in the pregnant and non-pregnant rat.J. Pharmacokin. Biopharm. 12:149–165 (1984).CrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1987

Authors and Affiliations

  • James M. Gallo
    • 1
  • Fred C. Lam
    • 1
  • Donald G. Perrier
    • 1
  1. 1.Department of Pharmacy and Department of Mathematics and StatisticsUniversity of OtagoDunedinNew Zealand

Personalised recommendations